Ewing Sarcoma
General Information
Randomized Phase 2 Trial Evaluating the Addition of the IGF-lR Monoclonal Antibody Ganitumab (AMG479, NSC#750008, IND#120449) to
Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Pediatrics
AEWS1221
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
Eligibility Information
Ineligibility Information